Dr. Shulman is on staff at CHOC Children's Hospital
CHOC Children's Clinic
1201 W. La Veta Ave.
Building: CHOC Clinic
Orange, CA 92868
map & directions
CHOC Children’s Specialty Center - Newport Beach
500 Superior Ave., Suite 140
Newport Beach, CA 92660
map & directions
An expert in the field of pediatric rheumatology, Dr. Shulman has acquired extensive training in the diagnosis and management of pediatric autoimmune and inflammatory conditions and research experience in molecular mechanisms of disease. He cares for patients with juvenile arthritis, systemic lupus erythematosus and related conditions, juvenile dermatomyositis, vasculitides, uveitis, periodic fever syndromes and other autoinflammatory diseases. Dr. Shulman frequently assists colleagues in the recognition and treatment of patients with pain amplification syndromes.
On the forefront of innovative education and research, Dr. Shulman performed translational studies in juvenile dermatomyositis at the University of Texas, Southwestern. Dr. Shulman’s publications encompass translational research in Kawasaki disease, anti-interleukin 1 treatment in SoJIA, critical care of the pediatric patient with rheumatic disease and molecular mechanisms of nuclear hormone receptors in the metabolic syndrome.
Dedicated to clinical excellence, Dr. Shulman is board certified in pediatrics and pediatric rheumatology. He received his medical degree and doctor of philosophy degree in cell regulation from the University of Texas, Southwestern Medical Center at Dallas. Dr. Shulman served his internship and residency in pediatrics in the Boston Combined Residency Program of Children’s Hospital Boston and Boston Medical Center. He completed his fellowship in pediatric rheumatology in the Children’s Hospital Boston division of allergy, immunology, and rheumatology.
The practice of pediatric rheumatology combines Dr. Shulman’s interests in working with an under-served population of kids, basic mechanisms of molecular immunology and in pediatric resident and rheumatology fellow education. Dr. Shulman has interests in literature and writing for a general readership. He writes the blog Left on Longwood and has contributed to Rheum School, a site for pediatric rheumatologists and trainees.
Nigrovic P.A., Mannion M., Prince F.H.M., Zeft A., Rabinovich C.E., van Rossum M.A.H., Cortis E., Pardeo M., Miettunen P.M., Janow G., Birmingham J., Eggebeen A., Janssen E., Shulman A.I., Son M.B., Hong S., Jones K., Ilowite N.T., Cron R.Q., Higgins G.C. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis. Arthritis and Rheumatism 63(2), 545-555 (2011).
Shulman A.I. and Punaro M. Critical care of the pediatric patient with rheumatic disease. Current Opinion in Pediatrics 23, 263-268 (2011).
Kentsis A., Shulman A., Ahmed S., Brennan E., Monuteaux M.C., Young-Ho L., Lipsett S., Paulo J.A., Dedeoglu F., Fuhlbrigge R., Bachur R., Bradwin G., Arditi M., Sundel R.P., Newburger J.W., Steen H., and Kim S. Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease. EMBO Molecular Medicine 4, 1-11 (2012).
Janssen E, Shulman A.I., and Sundel R. Autoimmune Diseases in Pediatric Allergy: Principles and Practice, 2nd edition. Leung D.Y.M., Sampson H.A., Geha R., and Szefler S.J. eds, Saunders, 160-169, 2011.